Thomas Boggs, Longtime Washington Influencer, Dies at 73

Thomas Hale Boggs Jr., whose name became synonymous with Washington lobbying through the success and growth of his former firm Patton Boggs, died Sunday night.

Special Reports

Legal Times

  • D.C. Superior Court Warns of ‘Adverse Impact’ of Vacancies

    By Zoe Tillman

    With three judicial vacancies in the District of Columbia Superior Court and a fourth seat opening in November, Chief Judge Lee Satterfield is warning the U.S. Senate about the "adverse impact" of leaving those posts unfilled.

  • SEC's Mary Jo White on Women in the Law

    By Jenna Greene

    In a speech Tuesday to the SAIS Global Conference on Women in the Boardroom, U.S. Securities and Exchange Commission Chairwoman Mary Jo White shared her experiences as a trailblazer in the law.

read more

Regulation

  • First Biosimilar Drugs Challenge Unfolds in Federal Circuit

    By Jenna Greene

    In the first appellate challenge to a new regulatory path for creating generic versions of biologic medicines derived from living organisms, advocates for Sandoz Inc. and Amgen Inc. on Wednesday faced tough questions from a three-judge panel at the U.S. Court of Appeals for the Federal Circuit.

  • EEOC Settles HIV Discrimination Case

    By Jenna Greene

    A Popeye’s Chicken franchisee that allegedly refused to hire a man because he was HIV-positive settled disability discrimination charges with the U.S. Equal Employment Opportunity Commission, agreeing to pay $25,000. Cases alleging HIV bias are a small portion of the EEOC’s docket, yielding generally modest settlements, but the litigation is meant to send a message.

read more

Surveys and Lists

Read More

Legal Education

read more

Calls For Nomination

Supreme Court Brief

read more

Litigation

  • Pharmaceutical Companies Reply to Proposed Drug-Name Rule

    By Amaris Elliott-Engel

    The comment period closed Monday regarding best practices for developing proprietary names for drugs to avoid medical errors, with a number of pharmaceutical companies weighing in with the U.S. Food and Drug Administration.

  • Chantix Plaintiffs Expert Seeks Pfizer Documents

    By Amaris Elliott-Engel

    A plaintiffs expert in the multidistrict litigation over the Chantix antismoking drug has moved to unseal court records in the advance of a U.S. Food and Drug Administration meeting next month to consider whether warnings about suicide risk are warranted.

read more

Who's Hiring

View more jobs at